# Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions

> **NCT05642845** · PHASE1 · COMPLETED · sponsor: **Pharmtechnology LLC** · enrollment: 50 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Atorvastatin film-coated tablet 40 mg
- **DRUG:** Liprimar® film-coated tablet 40 mg

## Key facts

- **NCT ID:** NCT05642845
- **Lead sponsor:** Pharmtechnology LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-19
- **Primary completion:** 2022-12-21
- **Final completion:** 2023-06-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05642845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05642845, "Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05642845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*